Replies to post #122741 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

PD..Thanks for this insight...she is driving significant change. Current trial protocols drive costs up and determination of effectiveness into the fog controlled by BP and big money. Ever question how the FDA allowed decades of expensive trials on AD(example) w/99.6% failure rate? Who has been served by these kinds of trials and results?

[quote This coordinated screening is at the heart of a master protocol and represents one of its chief advantages — more efficient use of patients and resources. Sponsors and research investigators benefit from a streamlined recruitment process, often of higher quality and yielding fewer screening failures and shorter recruitment times. Patients benefit through more opportunities to participate in investigational research and earlier access to potentially beneficial therapies. ][/quote]



Any rational assessment of the previous/current trial methods would question why it has been in use for so long. Changes like these take guts and brains. BTW, there are examples in industry where such process changes enable new thinking with better/faster/more reliable results...see telecomm industry TL data base methods using UTD systems protocols.